These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 6192312)
1. [Prostatic adenoma. Indication for therapy using sitosterine-containing phytopharmacologic agents]. Henneking K; Heckers H Med Welt; 1983 May; 34(21):625-32. PubMed ID: 6192312 [No Abstract] [Full Text] [Related]
2. [Treatment of prostatic adenoma with phytosterols]. Bauer KM; Otto G Med Welt; 1975 Jan; 26(1):7-10. PubMed ID: 48990 [No Abstract] [Full Text] [Related]
3. [Beta-sitosterin in the conservative therapy of prostatic adenoma. Experiences in urologic practice]. Bialluch W ZFA (Stuttgart); 1980 Sep; 56(26):1684-7. PubMed ID: 6161495 [No Abstract] [Full Text] [Related]
4. [Therapeutic efficacy of sitosterin prostate capsules in prostatic adenoma and prostatitis. Results of a field study]. Dörner G; Fritsche C ZFA (Stuttgart); 1982 Jan; 58(3):167-9. PubMed ID: 6176081 [No Abstract] [Full Text] [Related]
5. [How effective is beta-sistosterin?]. Kopper B Krankenpfl J; 1999; 37(7-8):285. PubMed ID: 10542556 [No Abstract] [Full Text] [Related]
7. [Measurement of urinary flow in general practice. Efficacy of beta-sitosterine]. Klingeberg J ZFA (Stuttgart); 1981 Oct; 57(28):1634-7. PubMed ID: 6170181 [No Abstract] [Full Text] [Related]
8. [Conservative therapy of prostatic adenoma as well as prostatitis with beta-sitosterol prostate capsules]. Karcher G Med Welt; 1982 Dec; 33(48):1763-6. PubMed ID: 6185822 [No Abstract] [Full Text] [Related]
9. [Results of a double-blind study on the effectiveness of a drug for conservative treatment of prostatic adenoma]. Ebbinghaus KD; Baur MP ZFA (Stuttgart); 1977 Jun; 53(18):1054-8. PubMed ID: 70119 [No Abstract] [Full Text] [Related]
10. [Current phytotherapeutic agents in the treatment of prostatic diseases]. Rocchietta S Minerva Med; 1977 Dec; 68(63):4261-4. PubMed ID: 74814 [No Abstract] [Full Text] [Related]
12. [Lowering of the serum cholesterol level with beta-sitosterin. Experiences from the medical practice]. Kandziora J Med Welt; 1980 Feb; 31(8):302-3. PubMed ID: 7374421 [No Abstract] [Full Text] [Related]
13. Tamsulosin for benign prostatic hyperplasia. Med Lett Drugs Ther; 1997 Oct; 39(1011):96. PubMed ID: 9379999 [No Abstract] [Full Text] [Related]
14. Stanol esters as a component of maximal dietary therapy in the National Cholesterol Education Program Adult Treatment Panel III report. Grundy SM Am J Cardiol; 2005 Jul; 96(1A):47D-50D. PubMed ID: 15992516 [TBL] [Abstract][Full Text] [Related]
15. [Stanols--a new perspective in treatment of hypercholesterolemia?]. Jankowski P; Bilo G; Bryniarski L; Bryniarska-Mirek E; Pajak A Przegl Lek; 2000; 57(11):655-8. PubMed ID: 11293214 [TBL] [Abstract][Full Text] [Related]
16. [The effectiveness of beta-sitosterol in treatment of benign prostatic hyperplasia]. Senge T; Windeler J; Berges RR; Trampisch HJ Urologe A; 1995 Mar; 34(2):130-1. PubMed ID: 7538710 [No Abstract] [Full Text] [Related]
18. [Effect of beta-sitosterin on the growth of the prostate]. Kassen A Krankenpfl J; 1999; 37(7-8):286. PubMed ID: 10542557 [No Abstract] [Full Text] [Related]
19. A multicentric, placebo-controlled, double-blind clinical trial of beta-sitosterol (phytosterol) for the treatment of benign prostatic hyperplasia. German BPH-Phyto Study group. Klippel KF; Hiltl DM; Schipp B Br J Urol; 1997 Sep; 80(3):427-32. PubMed ID: 9313662 [TBL] [Abstract][Full Text] [Related]
20. [Use of cernilton in the therapy of prostatic adenoma and chronic prostatitis]. Shaplygin LV; Sivakov AA Urologiia; 2007; (3):35-7, 39. PubMed ID: 17722618 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]